| Clip Of EpiPen Price Increases

Cost, Profits, and Revenue in the EPI Pen Market

User-Created Clip
by mcgorry
July 13, 2022

The chief executive officer of Mylan testified at a hearing on her company’s price increase on its EpiPen, an anti-anaphylaxis injection med… read more

The chief executive officer of Mylan testified at a hearing on her company’s price increase on its EpiPen, an anti-anaphylaxis injection medication. Lawmakers from both parties questioned Heather Bresch on the reasons for the price increase, which totaled more than 500 percent over a seven-year period. Representative Jason Chaffetz (R-UT) opens the hearing. close

Report Video Issue

Hosting Organization

Series

More information about

Cost, Profits, and Revenue in the EPI Pen Market

373 Views
Program ID:
415549-1
Category:
House Committee
Format:
House Committee
Location:
Washington, District of Columbia, United States
Purchase a Download

Cost, Profits, and Revenue in the EPI Pen Market

  • MP4 video - Standard
    Price:
    $4.99
  • MP3 audio - Standard
    Price:
    $0.99

User Created Clips from This Video

View all clips from this video